Shiying Li
Key Laboratory Of Biological Targeting Diagnosis, The NMPA And State Key Laboratory Of Respiratory Disease, 510700, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Legumain-activated radio-immunological synergist potentiates the abscopal effect via dual CD47/PD-L1 blockade and macrophage repolarization.
Journal: Biomaterials
Published: February 20, 2026
Nano-co-delivery Systems Combining Chemical and Photodynamic Therapy against Breast Cancer.
Journal: Current drug delivery
Published: November 10, 2025
Zinc and ascorbic acid synergistically alleviate cadmium toxicity in wheat by modulating transporter genes and antioxidant defense.
Journal: Ecotoxicology and environmental safety
Published: November 05, 2025
Stearic acid-modified PSMA-targeting peptide-drug conjugate for long-acting prostate cancer therapy.
Stearic acid-modified PSMA-targeting peptide-drug conjugate for long-acting prostate cancer therapy.
Journal: Chemical science
Published: October 25, 2025
Metal-drug coordinated nanozymes for ROS scavenging and Kupffer cell polarization to alleviate drug-induced liver injury.
Journal: Acta pharmaceutica Sinica. B
Published: September 17, 2025
Targeting S1PR1 in Thyroid Cancer: Functional Characterization and Proteasome-Mediated Suppression by Quercetin.
Journal: Molecular carcinogenesis
Published: August 25, 2025
Targeting Peptostreptococcus anaerobius with an Iron-Based Nanozyme Reverses Ferroptosis Resistance and Enhances Antitumor Immunity in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 24, 2025
CD169+ Macrophage-Targeted Immunomodulator to Restore Phagocytic Function and Enhance Antigen Presentation for Lymphatic Metastasis Eradication.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 29, 2025
A dual PROTAC nanocarrier amplifies DNA damage and STING activation for cancer immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 10, 2025
Lymph node targeting nanomedicines for tumor immunotherapy.
Journal: Biomaterials
Published: June 17, 2025
A multistage cost-effective strategy for the molecular diagnosis of unexplained vision loss patients: practice in inherited ocular fundus disease.
Journal: Molecular genetics and genomics : MGG
Published: May 09, 2025
Last Updated: 09/26/2026